alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2021081EN.01000601.xml

| 10.3.2021 | EN | Official Journal of the European Union | C 81/6 |
| --- | --- | --- | --- |

10.3.2021

EN

Official Journal of the European Union

C 81/6

---

Euro exchange rates (1)

9 March 2021

(2021/C 81/06)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1894 |
| JPY | Japanese yen | 129,50 |
| DKK | Danish krone | 7,4366 |
| GBP | Pound sterling | 0,85704 |
| SEK | Swedish krona | 10,1360 |
| CHF | Swiss franc | 1,1071 |
| ISK | Iceland króna | 151,75 |
| NOK | Norwegian krone | 10,0838 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 26,288 |
| HUF | Hungarian forint | 366,83 |
| PLN | Polish zloty | 4,5843 |
| RON | Romanian leu | 4,8870 |
| TRY | Turkish lira | 9,1023 |
| AUD | Australian dollar | 1,5440 |
| CAD | Canadian dollar | 1,4990 |
| HKD | Hong Kong dollar | 9,2325 |
| NZD | New Zealand dollar | 1,6607 |
| SGD | Singapore dollar | 1,6011 |
| KRW | South Korean won | 1 353,91 |
| ZAR | South African rand | 18,3128 |
| CNY | Chinese yuan renminbi | 7,7478 |
| HRK | Croatian kuna | 7,5913 |
| IDR | Indonesian rupiah | 17 140,98 |
| MYR | Malaysian ringgit | 4,8974 |
| PHP | Philippine peso | 57,724 |
| RUB | Russian rouble | 87,9711 |
| THB | Thai baht | 36,597 |
| BRL | Brazilian real | 6,9553 |
| MXN | Mexican peso | 25,3635 |
| INR | Indian rupee | 86,8270 |

Currency

Exchange rate

USD

US dollar

1,1894

JPY

Japanese yen

129,50

DKK

Danish krone

7,4366

GBP

Pound sterling

0,85704

SEK

Swedish krona

10,1360

CHF

Swiss franc

1,1071

ISK

Iceland króna

151,75

NOK

Norwegian krone

10,0838

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

26,288

HUF

Hungarian forint

366,83

PLN

Polish zloty

4,5843

RON

Romanian leu

4,8870

TRY

Turkish lira

9,1023

AUD

Australian dollar

1,5440

CAD

Canadian dollar

1,4990

HKD

Hong Kong dollar

9,2325

NZD

New Zealand dollar

1,6607

SGD

Singapore dollar

1,6011

KRW

South Korean won

1 353,91

ZAR

South African rand

18,3128

CNY

Chinese yuan renminbi

7,7478

HRK

Croatian kuna

7,5913

IDR

Indonesian rupiah

17 140,98

MYR

Malaysian ringgit

4,8974

PHP

Philippine peso

57,724

RUB

Russian rouble

87,9711

THB

Thai baht

36,597

BRL

Brazilian real

6,9553

MXN

Mexican peso

25,3635

INR

Indian rupee

86,8270

---

(1)  Source: reference exchange rate published by the ECB.

---
In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 99-542V

(Not to be published)

* * * * * * * * * * * * * * * * * * * * * * * * * 

*

ADAEL SHINN, mother and *

natural guardian of P.S., a minor, *

*

Petitioner, * 

* Filed: July 17, 2014

v. *

* Decision on Attorney’s

SECRETARY OF HEALTH AND * Fees and Costs

HUMAN SERVICES *

*

Respondent. *

*

* * * * * * * * * * * * * * * * * * * * * * * * * 

DECISION1(ATTORNEY FEES AND COSTS)

In this case under the National Vaccine Injury Compensation Program,2I issued a 

decision on November 26, 2013. On July 16, 2014, the parties filed a joint stipulation of facts

concerning attorneys’ fees and costs in this matter. The parties’ stipulation requests a total 

payment of $16,500.00, representing attorney’s fees and costs for work performed by the law 

firm of Clifford J. Shoemaker. 

I find that this petition was brought in good faith and that there existed a reasonable basis 

for the claim. Therefore, an award for fees and costs is appropriate, pursuant to 42 U.S.C. § 

300aa-15(b) and (e)(1). Further, the proposed amount seems reasonable and appropriate. 

Accordingly, I hereby award the total $16,500.00 as a lump sum in the form of a check 

payable jointly to petitioner and petitioner’s counsel, Clifford J. Shoemaker.

 

1 The undersigned intends to post this decision on the United States Court of Federal Claims’ website, in accordance 

with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 

U.S.C. § 3501 note (2006)). As provided by Vaccine Rule 18(b), each party has 14 days within which to request 

redaction “of any information furnished by that party (1) that is trade secret or commercial or financial information 

and is privileged or confidential, or (2) that are medical files and similar files the disclosure of which would 

constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, “the entire” decision will be 

available to the public. Id.

2 The applicable statutory provisions defining the program are found at 42 U.S.C. § 300aa-10 et seq. (2006). 
In the absence of a timely-filed motion for review filed pursuant to Appendix B of the 

Rules of the U.S. Court of Federal Claims, the clerk of the court shall enter judgment in 

accordance herewith.3

IT IS SO ORDERED

 /s/ George L. Hastings, Jr. 

 George L. Hastings, Jr.

 Special Master

 

3

Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by filing a joint notice renouncing the 

right to seek review.
#### DeFORD v. GLEASON et al.

(Supreme Court, Appellate Division, Fourth Department.

March 21, 1906.)

Action by Thomas DeFord against Thomas W. Gleason and others.

No opinion. Order affirmed, with $10 costs and disbursements.
EXHIBIT 32(a)
 
 PHARMOS CORPORATION
 SECTION 1350 CERTIFICATIONS
 
 In connection with the annual report of PHARMOS CORPORATION, a Nevada corporation (the "Company"), on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission (the "Report"), I, ROBERT F. JOHNSTON, Executive Chairman (Principal Executive Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
 
 (1) the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
 
 (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
 This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.
 
 Date: February 17, 2011
 
 By: /s/ Robert F. Johnston
 
 
 
 In connection with the annual report of PHARMOS CORPORATION, a Nevada corporation (the "Company"), on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission (the "Report"), I, S. COLIN NEILL, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
 
 (1) the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
 
 (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
 This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.
 
 Date: February 17, 2011
 
 By: /s/ S. Colin Neill
 
 
 A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to Pharmos Corporation and will be retained by Pharmos Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
#### 422.803 Responsibilities.

The contracting office shall submit questions involving the applicability of Executive Order 11246 and FAR subpart 22.8 through the HCA to the SPE for resolution.
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NO. WR-84,173-02

EX PARTE LADEREK ADARIOUS FULLER, Applicant

ON APPLICATION FOR A WRIT OF HABEAS CORPUS

CAUSE NO. W08-53000-V(B) IN THE 292ND DISTRICT COURT

FROM DALLAS COUNTY

Per curiam.

O R D E R

Pursuant to the provisions of Article 11.07 of the Texas Code of Criminal Procedure, the

clerk of the trial court transmitted to this Court this application for a writ of habeas corpus. Ex parte

Young, 418 S.W.2d 824, 826 (Tex. Crim. App. 1967). Applicant was convicted of capital murder

and sentenced to life imprisonment. The Fifth Court of Appeals affirmed his conviction. Fuller v.

State, No. 05-09-01099-CR (Tex. App. — Dallas, July 11, 2014) (not designated for publication).

Applicant contends that his conviction was based on the material false testimony of

accomplice-witness Demetrius Ellis. Ellis has submitted an affidavit in which he states that his trial

testimony indicating that Applicant took part in planning the robbery and was the shooter who killed

the victim during the course of the robbery was false. The State responds that Ellis’s affidavit is not
2

credible. The trial court has not entered findings of fact and conclusions of law. 

Applicant has alleged facts that, if true, might entitle to relief. Ex parte Weinstein, 421

S.W.3d 656 (Tex. Crim. App. 2014). In these circumstances, additional facts are needed. As we

held in Ex parte Rodriguez, 334 S.W.2d 294, 294 (Tex. Crim. App. 1960), the trial court is the

appropriate forum for findings of fact. The trial court may use any means set out in TEX. CODE

CRIM. PROC. art. 11.07, § 3(d). In the appropriate case, the trial court may rely on its personal

recollection. Id.

If the trial court elects to hold a hearing, it shall determine whether Applicant is indigent. 

If Applicant is indigent and wishes to be represented by counsel but is not represented by counsel,

the trial court shall appoint an attorney to represent Applicant at the hearing. TEX. CODE CRIM.

PROC. art. 26.04. 

The trial court shall make findings of fact and conclusions of law as to whether the trial

testimony of Demetrius Ellis was false, and if so, whether there is a reasonable likelihood that the

false testimony affected the judgment of the jury. The trial court shall also make any other findings

of fact and conclusions of law that it deems relevant and appropriate to the disposition of Applicant’s

claim for habeas corpus relief.

This application will be held in abeyance until the trial court has resolved the fact issues. The

issues shall be resolved within 90 days of this order. A supplemental transcript containing all

affidavits and interrogatories or the transcription of the court reporter’s notes from any hearing or

deposition, along with the trial court’s supplemental findings of fact and conclusions of law, shall

be forwarded to this Court within 120 days of the date of this order. Any extensions of time must

be requested by the trial court and shall be obtained from this Court.
3

Filed: May 1, 2019

Do not publish
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 00-7433

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

JOSEPH EDWARDS MONROE, a/k/a Slim,

Defendant - Appellant.

Appeal from the United States District Court for the Western

District of Virginia, at Charlottesville. Henry C. Morgan, Jr.,

District Judge, sitting by designation. (CR-94-41)

Submitted: July 26, 2001 Decided: July 31, 2001

Before WILKINS, LUTTIG, and TRAXLER, Circuit Judges.

Affirmed in part and dismissed in part by unpublished per curiam

opinion.

Joseph Edwards Monroe, Appellant Pro Se. Sharon Burham, OFFICE OF

THE UNITED STATES ATTORNEY, Roanoke, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
* To the extent that Monroe seeks to appeal the district

court’s order entered on April 14, 2000, which denied his codefendant’s § 3582 motion, we dismiss the appeal.

2

PER CURIAM:

Joseph Edwards Monroe seeks to appeal the district court’s

order denying his motion to reduce his sentence filed under 18

U.S.C.A. § 3582 (West 2000),* and the order finding that Monroe had

not established excusable neglect warranting an extension of the

appeal period. We have reviewed the record and the district

court’s order regarding excusable neglect and find no abuse of

discretion. United States v. Breit, 754 F.2d 526, 529 (4th Cir.

1985) (stating standard of review). Accordingly, we affirm the

excusable neglect determination on the reasoning of the district

court. United States v. Monroe, No. CR-94-41 (W.D. Va. Oct. 10,

2000).

With regard to Monroe’s appeal from the order denying his

§ 3582 motion, we dismiss the appeal for lack of jurisdiction. In

criminal cases, the defendant must file his notice of appeal within

ten days of the entry of judgment. Fed. R. App. P. 4(b)(1)(A).

With or without a motion, the district court may grant an extension

of time to file of up to thirty days upon a showing of excusable

neglect. Fed. R. App. P. 4(b)(4); United States v. Alvarez, 210

F.3d 309, 310 (5th Cir. 2000) (holding that § 3582 proceeding is

criminal in nature and ten-day appeal period applies); United
3

States v. Reyes, 759 F.2d 351, 353 (4th Cir. 1985). This appeal

period is “mandatory and jurisdictional.” Browder v. Director,

Dep’t of Corrections, 434 U.S. 257, 264 (1978) (quoting United

States v. Robinson, 361 U.S. 220, 229 (1960)); United States v.

Raynor, 939 F.2d 191, 197 (4th Cir. 1991).

The district court’s order was entered on the docket on March

25, 1999. Monroe’s notice of appeal was filed nunc pro tunc on May

14, 2000. Because Monroe failed to file a timely notice of appeal,

to obtain an extension based upon excusable neglect, or to obtain

a reopening of the appeal period, we deny leave to proceed in forma

pauperis and dismiss this portion of the appeal. We dispense with

oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would

not aid the decisional process.

AFFIRMED IN PART AND DISMISSED IN PART
Top of Form

# Preschool Development Grants

## Development Grants

# Panel Review by Applicant

## Hawaii

Bottom of Form

# _1479585299.unknown
## FY 2023

- Project Abstract(s):    MS Word  (47K)

## FY 2022

- Project Abstract(s):    MS Word  (29K)

## FY 2021

- Project Abstract(s):    PDF  (238K)

FIPSE Home
#### 43.202 Authority to issue change orders.

Change orders shall be issued by the contracting officer except when authority is delegated to an administrative contracting officer (see 42.202(c)).
# C_2019307EN.01000201.xml

| 11.9.2019 | EN | Official Journal of the European Union | C 307/2 |
| --- | --- | --- | --- |

11.9.2019

EN

Official Journal of the European Union

C 307/2

---

Euro exchange rates (1)

10 September 2019

(2019/C 307/02)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1040 |
| JPY | Japanese yen | 118,52 |
| DKK | Danish krone | 7,4608 |
| GBP | Pound sterling | 0,89300 |
| SEK | Swedish krona | 10,7445 |
| CHF | Swiss franc | 1,0943 |
| ISK | Iceland króna | 138,70 |
| NOK | Norwegian krone | 9,9125 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,869 |
| HUF | Hungarian forint | 331,61 |
| PLN | Polish zloty | 4,3339 |
| RON | Romanian leu | 4,7334 |
| TRY | Turkish lira | 6,3736 |
| AUD | Australian dollar | 1,6103 |
| CAD | Canadian dollar | 1,4536 |
| HKD | Hong Kong dollar | 8,6559 |
| NZD | New Zealand dollar | 1,7194 |
| SGD | Singapore dollar | 1,5227 |
| KRW | South Korean won | 1 315,87 |
| ZAR | South African rand | 16,1993 |
| CNY | Chinese yuan renminbi | 7,8445 |
| HRK | Croatian kuna | 7,3938 |
| IDR | Indonesian rupiah | 15 505,68 |
| MYR | Malaysian ringgit | 4,6053 |
| PHP | Philippine peso | 57,425 |
| RUB | Russian rouble | 72,2447 |
| THB | Thai baht | 33,799 |
| BRL | Brazilian real | 4,5234 |
| MXN | Mexican peso | 21,5665 |
| INR | Indian rupee | 79,3815 |

Currency

Exchange rate

USD

US dollar

1,1040

JPY

Japanese yen

118,52

DKK

Danish krone

7,4608

GBP

Pound sterling

0,89300

SEK

Swedish krona

10,7445

CHF

Swiss franc

1,0943

ISK

Iceland króna

138,70

NOK

Norwegian krone

9,9125

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,869

HUF

Hungarian forint

331,61

PLN

Polish zloty

4,3339

RON

Romanian leu

4,7334

TRY

Turkish lira

6,3736

AUD

Australian dollar

1,6103

CAD

Canadian dollar

1,4536

HKD

Hong Kong dollar

8,6559

NZD

New Zealand dollar

1,7194

SGD

Singapore dollar

1,5227

KRW

South Korean won

1 315,87

ZAR

South African rand

16,1993

CNY

Chinese yuan renminbi

7,8445

HRK

Croatian kuna

7,3938

IDR

Indonesian rupiah

15 505,68

MYR

Malaysian ringgit

4,6053

PHP

Philippine peso

57,425

RUB

Russian rouble

72,2447

THB

Thai baht

33,799

BRL

Brazilian real

4,5234

MXN

Mexican peso

21,5665

INR

Indian rupee

79,3815

---

(1)  Source: reference exchange rate published by the ECB.

---
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityResearch on Law Enforcement Responses to Opioid Overdoses (Funding Opportunity)

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

## Breadcrumb

            -  Announcements 
            -           Resource: Adolescent Health: What Works In Schools      

# Resource: Adolescent Health: What Works In Schools

This evidence-based approach to school-based HIV and STD prevention includes quality sexual health education, connecting students to sexual health services, and establishing safe and supportive school environments. These strategies benefit all students and can be tailored to address health outcomes other than sexual risk behaviors, including high-risk substance use, violence victimization, and mental health. Taking this approach improves protective factors and health outcomes for students that can last a lifetime. **Learn more.**
# C_2020185EN.01000201.xml

| 4.6.2020 | EN | Official Journal of the European Union | C 185/2 |
| --- | --- | --- | --- |

4.6.2020

EN

Official Journal of the European Union

C 185/2

---

Euro exchange rates (1)

3 June 2020

(2020/C 185/02)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1194 |
| JPY | Japanese yen | 121,54 |
| DKK | Danish krone | 7,4547 |
| GBP | Pound sterling | 0,89065 |
| SEK | Swedish krona | 10,4588 |
| CHF | Swiss franc | 1,0793 |
| ISK | Iceland króna | 151,00 |
| NOK | Norwegian krone | 10,6777 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 26,660 |
| HUF | Hungarian forint | 345,89 |
| PLN | Polish zloty | 4,4135 |
| RON | Romanian leu | 4,8393 |
| TRY | Turkish lira | 7,5703 |
| AUD | Australian dollar | 1,6280 |
| CAD | Canadian dollar | 1,5173 |
| HKD | Hong Kong dollar | 8,6757 |
| NZD | New Zealand dollar | 1,7532 |
| SGD | Singapore dollar | 1,5656 |
| KRW | South Korean won | 1 364,09 |
| ZAR | South African rand | 19,0844 |
| CNY | Chinese yuan renminbi | 7,9599 |
| HRK | Croatian kuna | 7,5720 |
| IDR | Indonesian rupiah | 15 885,35 |
| MYR | Malaysian ringgit | 4,7703 |
| PHP | Philippine peso | 55,923 |
| RUB | Russian rouble | 77,0055 |
| THB | Thai baht | 35,339 |
| BRL | Brazilian real | 5,7993 |
| MXN | Mexican peso | 24,2772 |
| INR | Indian rupee | 84,5055 |

Currency

Exchange rate

USD

US dollar

1,1194

JPY

Japanese yen

121,54

DKK

Danish krone

7,4547

GBP

Pound sterling

0,89065

SEK

Swedish krona

10,4588

CHF

Swiss franc

1,0793

ISK

Iceland króna

151,00

NOK

Norwegian krone

10,6777

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

26,660

HUF

Hungarian forint

345,89

PLN

Polish zloty

4,4135

RON

Romanian leu

4,8393

TRY

Turkish lira

7,5703

AUD

Australian dollar

1,6280

CAD

Canadian dollar

1,5173

HKD

Hong Kong dollar

8,6757

NZD

New Zealand dollar

1,7532

SGD

Singapore dollar

1,5656

KRW

South Korean won

1 364,09

ZAR

South African rand

19,0844

CNY

Chinese yuan renminbi

7,9599

HRK

Croatian kuna

7,5720

IDR

Indonesian rupiah

15 885,35

MYR

Malaysian ringgit

4,7703

PHP

Philippine peso

55,923

RUB

Russian rouble

77,0055

THB

Thai baht

35,339

BRL

Brazilian real

5,7993

MXN

Mexican peso

24,2772

INR

Indian rupee

84,5055

---

(1)  Source: reference exchange rate published by the ECB.

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               MAR-31-2000
<CASH>                                          22,040
<SECURITIES>                                 1,384,534
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                68,138
<PP&E>                                          26,478
<DEPRECIATION>                                   1,125
<TOTAL-ASSETS>                               1,770,537
<CURRENT-LIABILITIES>                        1,389,402
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     57,553
<COMMON>                                       129,764
<OTHER-SE>                                     193,818
<TOTAL-LIABILITY-AND-EQUITY>                 1,770,537
<SALES>                                              0
<TOTAL-REVENUES>                             1,016,646
<CGS>                                          466,063
<TOTAL-COSTS>                                1,122,226
<OTHER-EXPENSES>                               225,298
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,753
<INCOME-PRETAX>                              (346,631)
<INCOME-TAX>                                     3,300
<INCOME-CONTINUING>                          (349,931)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (349,931)
<EPS-BASIC>                                      (.08)
<EPS-DILUTED>                                    (.08)


</TABLE>